NMR structure of an inhibitory R2 C-terminal peptide bound to mouse ribonucleotide reductase R1 subunit

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature Structural Biology

• Publication date

  1995-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/NSB1195-951PMID 7583667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo

  1994cited by this paper
• Purification, characterization, and localization of subunit interaction area of recombinant mouse ribonucleotide reductase R1 subunit.

  1994cited by this paper
• Use of the Transferred Nuclear Overhauser Effect To Determine the Conformations of Ligands Bound to Proteins

  1994cited by this paper
• Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

  1994cited by this paper
• 1H NMR studies of mouse ribonucleotide reductase: the R2 protein carboxyl-terminal tail, essential for subunit interaction, is highly flexible but becomes rigid in the presence of protein R1.

  1994cited by this paper
• Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit.

  1994cited by this paper
• Structure of ribonucleotide reductase protein R1

  1994cited by this paper
• R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase.

  1993cited by this paper
• Ribonucleotide reductases and their occurrence in microorganisms: a link to the RNA/DNA transition.

  1993cited by this paper
• The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.

  1993cited by this paper
• Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy.

  1993cited by this paper
• High level expression of the large subunit of mouse ribonucleotide reductase in a baculovirus system

  1993cited by this paper
• Exploring the limits of precision and accuracy of protein structures determined by nuclear magnetic resonance spectroscopy.

  1993cited by this paper
• A model for the role of multiple cysteine residues involved in ribonucleotide reduction: amazing and still confusing.

  1992cited by this paper
• X-PLOR Version 3.1: A System for X-ray Crystallography and NMR

  1992cited by this paper
• Theoretical evaluation of the two-dimensional transferred nuclear overhauser effect

  1991cited by this paper
• Specific inhibition of ribonucleotide reductases by peptides corresponding to the C-terminal of their second subunit.

  1991cited by this paper
• Carboxyl-terminal peptides as probes for Escherichia coli ribonucleotide reductase subunit interaction: kinetic analysis of inhibition studies.

  1991cited by this paper
• Purification and characterization of recombinant mouse and herpes simplex virus ribonucleotide reductase R2 subunit.

  1991cited by this paper
• Investigation of an octapeptide inhibitor of Escherichia coli ribonucleotide reductase by transferred nuclear Overhauser effect spectroscopy.

  1991cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• Ribonucleotide reductases.

  1990cited by this paper
• Determination of three-dimensional structures of proteins and nucleic acids in solution by nuclear magnetic resonance spectroscopy.

  1989cited by this paper
• NMR of proteins and nucleic acids

  1988cited by this paper
• Ribonucleotide reductase as a chemotherapeutic target.

  1988cited by this paper
• Turns in peptides and proteins.

  1985cited by this paper
• Optimization by Simulated Annealing

  1983cited by this paper
• Theory and applications of the transferred nuclear overhauser effect to the study of the conformations of small ligands bound to proteins

  1982cited by this paper
• Reduction of ribonucleotides.

  1979cited by this paper

• Photocontrol of peptide secondary structure through non-azobenzene photoswitches

  2019cites this paper
• A new set of atomic radii for accurate estimation of solvation free energy by Poisson–Boltzmann solvent model

  2014cites this paper
• The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitors.

  2014cites this paper
• A Novel Clade of Unique Eukaryotic Ribonucleotide Reductase R2 Subunits is Exclusive to Apicomplexan Parasites

  2013cites this paper
• The structural basis for the allosteric regulation of ribonucleotide reductase.

  2013cites this paper
• Ribonucleotide reductase as a target to control apicomplexan diseases.

  2012cites this paper
• Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy

  2011cites this paper
• Peptidomimetic Enzyme Inhibitors : Targeting M. tuberculosis Ribonucleotide Reductase and Hepatitis C Virus NS3 Protease

  2010cites this paper
• The structural basis for peptidomimetic inhibition of eukaryotic ribonucleotide reductase: a conformationally flexible pharmacophore.

  2008cites this paper
• Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents.

  2007cites this paper
• Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly.

  2006cites this paper
• Defining the active form of ribonucleotide reductase from Saccharomyces cerevisiae in vitro and in vivo

  2005cites this paper
• Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy.

  2005cites this paper
• Peptide inhibitors of mammalian ribonucleotide reductase.

  2005cites this paper
• Design, synthesis, and evaluation of octahydropyranopyrrole-based inhibitors of mammalian ribonucleotide reductase.

  2005cites this paper
• Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer?

  2003cites this paper
• Oligopeptide inhibition of class I ribonucleotide reductases

  2003cites this paper
• Affinity-driven selection of tripeptide inhibitors of ribonucleotide reductase.

  2002cites this paper
• Crystal structure of the di-iron/radical protein of ribonucleotide reductase from Corynebacterium ammoniagenes.

  2002cites this paper
• C-terminal peptides as inhibitors and probes of mammalian ribonucleotide reductase

  2002cites this paper
• Complete Relaxation and Conformational Exchange Matrix (CORCEMA) Analysis of NOESY Spectra of Reversibly Forming Ligand-Receptor Complexes Application to Transferred NOESY

  2002cites this paper
• Sequencing cyclic peptide inhibitors of mammalian ribonucleotide reductase by electrospray ionization mass spectrometry.

  2001cites this paper
• Structure and function of the radical enzyme ribonucleotide reductase.

  2001cites this paper
• Toward a rational design of peptide inhibitors of ribonucleotide reductase: structure-function and modeling studies.

  2001cites this paper
• Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase.

  2000cites this paper
• Ribonucleotide reductase: A new target for antiparasite therapies.

  1999cites this paper
• Synthesis and biological activity of cyclic peptide inhibitors of ribonucleotide reductase.

  1999cites this paper
• Chimeric small subunit inhibitors of mammalian ribonucleotide reductase: a dual function for the R2 C-terminus?

  1998cites this paper
• Design and synthesis of a tetrahydropyran-based inhibitor of mammalian ribonucleotide reductase.

  1998cites this paper
• Synthetic interface peptides as inactivators of multimeric enzymes: inhibitory and conformational properties of three fragments from Lactobacillus casei thymidylate synthase.

  1998cites this paper
• Electron paramagnetic resonance and nuclear magnetic resonance studies of class I ribonucleotide reductase.

  1996cites this paper
• The three-dimensional structure of mammalian ribonucleotide reductase protein R2 reveals a more-accessible iron-radical site than Escherichia coli R2.

  1996cites this paper